The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Self-citationTreating rheumatoid arthritis to target: recommendations of an international task force
Smolen, J. S., Aletaha, D., Bijlsma, J. W. J., Breedveld, F. C., Boumpas, D., Burmester, G., Combe, B., Cutolo, M., de Wit, M., Dougados, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123919 · Cited by 2,100
Self-citationPanahi, M., Naderi, M., Morteza, T. S., & Parizadeh, S. M. J. (2007) · Cited by 1,722
Cohen, S. B., Emery, P., Greenwald, M. W., Dougados, M., Furie, R. A., Genovese, M. C., Keystone, E. C., Loveless, J. E., Burmester, G., Cravets, M. W., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22025 · Cited by 1,638
Self-citationvon Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Clinical guidelines: Developing guidelines
Shekelle, P. G., Woolf, S. H., Eccles, M., & Grimshaw, J. (1999) · BMJ · doi:10.1136/bmj.318.7183.593 · Cited by 1,222
Emery, P., Fleischmann, R., Filipowicz‐Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A. J., van Vollenhoven, R. F., Li, N. F., Agarwal, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21778 · Cited by 1,060
Self-citationHarpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,037
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Liaw, Y.-F., Leung, N., Kao, J.-H., Piratvisuth, T., Gane, E., Han, K.-H., Guan, R., Lau, G. K. K., Locarnini, S., & for the Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver (2008) · Hepatology International · doi:10.1007/s12072-008-9080-3 · Cited by 867
Carson, K. R., Evens, A. M., Richey, E. A., Habermann, T. M., Focosi, D., Seymour, J. F., Laubach, J., Bawn, S. D., Gordon, L. I., Winter, J. N., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186999 · Cited by 866
Weinbaum, C. M., Mast, E. E., & Ward, J. W. (2009) · Hepatology · doi:10.1002/hep.22882 · Cited by 815
van Assen, S., Agmon-Levin, N., Elkayam, O., Cervera, R., Doran, M. F., Dougados, M., Emery, P., Geborek, P., Ioannidis, J. P. A., Jayne, D. R. W., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137216 · Cited by 630
Self-citationPregnancy outcomes after maternal exposure to rituximab
Chakravarty, E. F., Murray, E. R., Kelman, A., & Farmer, P. (2011) · Blood · doi:10.1182/blood-2010-07-295444 · Cited by 586
Leandro, M. J., Cambridge, G., Ehrenstein, M. R., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21617 · Cited by 560
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
Strangfeld, A. (2009) · JAMA · doi:10.1001/jama.2009.146 · Cited by 542
Glucocorticoid use, other associated factors, and the risk of tuberculosis
Jick, S. S., Lieberman, E. S., Rahman, M. U., & Choi, H. K. (2006) · Arthritis Care & Research · doi:10.1002/art.21705 · Cited by 477
Salliot, C., Dougados, M., & Gossec, L. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083188 · Cited by 477
Tolerability and safety of rituximab (MabThera®)
Kimby, E. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.05.007 · Cited by 470
Bingham, C. O., Looney, R. J., Deodhar, A., Halsey, N., Greenwald, M., Codding, C., Trzaskoma, B., Martin, F., Agarwal, S., & Kelman, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25034 · Cited by 459
Carson, K. R., Focosi, D., Major, E. O., Petrini, M., Richey, E. A., West, D. P., & Bennett, C. L. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70161-5 · Cited by 447
Smolen, J. S., Landewé, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., Gorter, S., Knevel, R., Nam, J., Schoels, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126532 · Cited by 409
Self-citationNam, J. L., Winthrop, K. L., van Vollenhoven, R. F., Pavelka, K., Valesini, G., Hensor, E. M. A., Worthy, G., Landewé, R., Smolen, J. S., Emery, P., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126573 · Cited by 406
Self-citationvan Assen, S., Holvast, A., Benne, C. A., Posthumus, M. D., van Leeuwen, M. A., Voskuyl, A. E., Blom, M., Risselada, A. P., de Haan, A., Westra, J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25033 · Cited by 371
Weinbaum, C. M., Williams, I., Mast, E. E., Wang, S. A., Finelli, L., Wasley, A., Neitzel, S. M., & Ward, J. W. (2008) · PubMed · Cited by 364
Emery, P., Deodhar, A., Rigby, W. F., Isaacs, J. D., Combe, B., Racewicz, A. J., Latinis, K., Abud-Mendoza, C., Szczepański, L. J., Roschmann, R. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119933 · Cited by 348
Self-citationKeystone, E., Fleischmann, R., Emery, P., Furst, D. E., van Vollenhoven, R., Bathon, J., Dougados, M., Baldassare, A., Ferraccioli, G., Chubick, A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23059 · Cited by 337
Self-citationThurlings, R. M., Vos, K., Wijbrandts, C. A., Zwinderman, A. H., Gerlag, D. M., & Tak, P. P. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080960 · Cited by 334
Self-citationRoll, P., Palanichamy, A., Kneitz, C., Dorner, T., & Tony, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22019 · Cited by 321
Tak, P. P., Rigby, W. F., Rubbert-Roth, A., Peterfy, C. G., van Vollenhoven, R. F., Stohl, W., Hessey, E., Chen, A., Tyrrell, H., & Shaw, T. M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137703 · Cited by 307
Self-citationGottenberg, J. ‐., Ravaud, P., Bardin, T., Cacoub, P., Cantagrel, A., Combe, B., Dougados, M., Flipo, R. M., Godeau, B., Guillevin, L., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27555 · Cited by 305
Self-citationLongterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
van VOLLENHOVEN, R. F., EMERY, P., BINGHAM, C. O., KEYSTONE, E. C., FLEISCHMANN, R., FURST, D. E., MACEY, K., SWEETSER, M., KELMAN, A., & RAO, R. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090856 · Cited by 287
Self-citationDevelopment of psoriasis after B cell depletion with rituximab
Dass, S., Vital, E. M., & Emery, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22811 · Cited by 237
Self-citationConsensus statement on the use of rituximab in patients with rheumatoid arthritis
Smolen, J. S., Keystone, E. C., Emery, P., Breedveld, F. C., Betteridge, N., Burmester, G. R., Dougados, M., Ferraccioli, G., Jaeger, U., Klareskog, L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061002 · Cited by 228
Self-citationKeystone, E., Emery, P., Peterfy, C. G., Tak, P. P., Cohen, S., Genovese, M. C., Dougados, M., Burmester, G. R., Greenwald, M., Kvien, T. K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085787 · Cited by 227
Self-citationHighly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis
Dass, S., Rawstron, A. C., Vital, E. M., Henshaw, K., McGonagle, D., & Emery, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23902 · Cited by 210
Self-citationWinthrop, K. L., Yamashita, S., Beekmann, S. E., Polgreen, P. M., & Infectious Diseases Society of America Emerging Infections Network (2008) · Clinical Infectious Diseases · doi:10.1086/587989 · Cited by 196
Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis
Vos, K., Thurlings, R. M., Wijbrandts, C. A., van Schaardenburg, D., Gerlag, D. M., & Tak, P. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22400 · Cited by 194
Self-citationRoll, P., Dörner, T., & Tony, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23473 · Cited by 187
Self-citationRubbert-Roth, A., Tak, P. P., Zerbini, C., Tremblay, J.-L., Carreno, L., Armstrong, G., Collinson, N., Shaw, T. M., & on behalf of the MIRROR Trial Investigators (2010) · Rheumatology · doi:10.1093/rheumatology/keq116 · Cited by 186
Self-citationKavanaugh, A., Rosengren, S., Lee, S. J., Hammaker, D., Firestein, G. S., Kalunian, K., Wei, N., & Boyle, D. L. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074229 · Cited by 178
Schoels, M., Wong, J., Scott, D. L., Zink, A., Richards, P., Landewé, R., Smolen, J. S., & Aletaha, D. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126714 · Cited by 165
Self-citationRepeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs
Popa, C., Leandro, M. J., Cambridge, G., & Edwards, J. C. W. (2006) · Rheumatology · doi:10.1093/rheumatology/kel393 · Cited by 164
Aletaha, D., & Smolen, J. S. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.02.004 · Cited by 163
Self-citationImmunology, immunopathology and immunity
Sell, S. (1973) · Arthritis & Rheumatism · doi:10.1002/art.1780160224 · Cited by 158
Artz, A. S., Somerfield, M. R., Feld, J. J., Giusti, A. F., Kramer, B. S., Sabichi, A. L., Zon, R. T., & Wong, S. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.0673 · Cited by 158
The Definition and Measurement of Disease Modification in Inflammatory Rheumatic Diseases
Aletaha, D., & Smolen, J. S. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2005.09.005 · Cited by 152
Self-citationB lymphocyte depletion therapy in children with refractory systemic lupus erythematosus
Marks, S. D., Patey, S., Brogan, P. A., Hasson, N., Pilkington, C., Woo, P. M., & Tullus, K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21351 · Cited by 144
Braun, J., Baraliakos, X., Listing, J., Fritz, C., Alten, R., Burmester, G. R., Krause, A., Schewe, S., Schneider, M., Sörensen, H., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075879 · Cited by 144
Self-citationDunleavy, K. M., Hakim, F. T., Kim, H. K., Janik, J. E., Grant, N., Nakayama, T., White, T., Wright, G. W., Kwak, L. W., Gress, R. E., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3198 · Cited by 136
Nakou, M., Katsikas, G., Sidiropoulos, P. I., Bertsias, G. K., Papadimitraki, E. D., Raptopoulou, A., Koutala, H., Papadaki, H. Α., Kritikos, H. D., & Boumpas, D. T. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2798 · Cited by 136
Vital, E. M. J., Dass, S. J., Rawstron, A. C., Buch, M. H., Goëb, V., Henshaw, K., Ponchel, F., & Emery, P. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27359 · Cited by 127
Self-citationBird, A. G. (1990) · Clinica Chimica Acta · doi:10.1016/0009-8981(90)90123-a · Cited by 126
Mease, P. J., Cohen, S. B., GAYLIS, N. B., Chubick, A., Kaell, A. T., Greenwald, M., Agarwal, S. K., YIN, M., & Kelman, A. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090442 · Cited by 125
Rehnberg, M., Amu, S., Tarkowski, A., Bokarewa, M. I., & Brisslert, M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2789 · Cited by 118
Thurlings, R. M., Teng, O. Y., Vos, K., Gerlag, D. M., Aarden, L. A., Stapel, S. O., van Laar, J. M., Tak, P. P., & Wolbink, G. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.109041 · Cited by 116
Self-citationFleischmann, R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24906 · Cited by 112
Nitta, E. M., Izutsu, K., Sato, T., Ota, Y., Takeuchi, K., Kamijo, A., Takahashi, K., Oshima, K., Kanda, Y., Chiba, S., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl393 · Cited by 105
Greenwald, M., Shergy, W. J., Kaine, J., Sweetser, M. T., Gilder, K. M., & Linnik, M. D. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30194 · Cited by 96
Zheng, W., Li, R.-S., Pan, H., He, D., Xu, R., Guo, T. B., Guo, Y.-J., & Zhang, J.-W. Z. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24625 · Cited by 95
Quartuccio, L., Fabris, M., Salvin, S., Atzeni, F., Saracco, M., Benucci, M., Cimmino, M. A., Morassi, P., Masolini, P., Pellerito, R., et al. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep314 · Cited by 95
Teng, Y. K. O., Levarht, E. W. N., Toes, R. E. M., Huizinga, T. W. J., & van Laar, J. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092791 · Cited by 92
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
Genovese, M. C., Breedveld, F. C., Emery, P., Cohen, S. B., Keystone, E., Matteson, E. L., Baptiste, Y. J., Chai, A., Burke, L. S., Reiss, W. G., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101675 · Cited by 86
Self-citationChatzidionysiou, K., Lie, E., Nasonov, E. L., Lukina, G. V., Hetland, M. L., Tarp, U., van Riel, P. L. C. M., Nordström, D., Gómez-Reino, J. J., Pavelká, K., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200003 · Cited by 78
Self-citationClinical Effects and Safety of Rituximab for Treatment of Refractory Pediatric Autoimmune Diseases
El-Hallak, M., Binstadt, B. A., Leichtner, A. M., Bennett, C. M., Neufeld, E. J., Fuhlbrigge, R. C., Zurakowski, D., & Sundel, R. P. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.10.067 · Cited by 72
van der Kolk, L. E., Grillo-López, A. J., Baars, J. W., & van Oers, M. H. J. (2003) · Leukemia · doi:10.1038/sj.leu.2402995 · Cited by 64
Thurlings, R. M., Vos, K., Gerlag, D. M., & Tak, P. P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24035 · Cited by 64
Self-citationImmunology, Immunopathology, and Immunity
Sell, S. (2001) · Wiley eBooks · doi:10.1128/9781555818012 · Cited by 58
Kielhorn, A., Porter, D. R., Diamantopoulos, A., & Lewis, G. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802321683 · Cited by 56
Emery, P., Mease, P. J., Rubbert‐Roth, A., Curtis, J. R., Müller‐Ladner, U., GAYLIS, N. B., Williams, S., Reynard, M., & Tyrrell, H. E. J. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker253 · Cited by 54
Self-citationSalar, A., Casao, D., Cervera, M., Pedro, C., Calafell, M., Abella, E., Álvarez‐Larrán, A., & Besses, C. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00713.x · Cited by 46
Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab
Kuek, A. Z. C., Hazleman, B. L., Gaston, H., & Östör, A. J. K. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel301 · Cited by 46
Dieguez‐Gonzalez, R., Akar, S., Calaza, M., Pérez-Pampín, E. M., Costas, J., Torres, M. L., Vicario, J. L., Velloso, M. L., Navarro, F., Narváez, J., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.087304 · Cited by 43
Rapid infusion of rituximab over 60 min
Tuthill, M. H., Crook, T., Corbet, T., King, J., & Webb, A. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01215.x · Cited by 41
Rapid Infusion Rituximab Changing Practice for Patient Care
Zahrani, A. A., Ibrahim, N. A. R., & Eid, A. A. (2009) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155208100527 · Cited by 33
Late‐onset neutropenia following RCHOP chemotherapy in diffuse large B‐cell lymphoma
Lai, G. G. Y., Lim, S. T., Tao, M., Chan, A., Li, H., & Quek, R. H. H. (2009) · American Journal of Hematology · doi:10.1002/ajh.21420 · Cited by 29
Rapid-infusion rituximab in lymphoma treatment
Provencio, M., Cerdeira, S., Bonilla, F., Sánchez, A., & España, P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj103 · Cited by 28
Chiang, J., Chan, A., Shih, V., Hee, S. W., Tao, M., & Lim, S. T. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0583-z · Cited by 26
Cruyssen, B. V., Durez, P., Westhovens, R., Kaiser, M.-J., Hoffman, I. E. A., Keyser, F. D., & The MIRA Study Group (2010) · Arthritis Research & Therapy · doi:10.1186/ar3129 · Cited by 22
Cited by
Smolen, J. S., Landewé, R. B. M., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A., van Vollenhoven, R. F., de Wit, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,710
Self-citationSmolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Self-citationSmolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Self-citationSmolen, J. S., Landewé, R., Breedveld, F. C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204573 · Cited by 1,763
Self-citationStroke and the immune system: from pathophysiology to new therapeutic strategies
Macrez, R., Ali, C., Toutirais, O., Le Mauff, B., Defer, G., Dirnagl, U., & Vivien, D. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70066-7 · Cited by 560
Metadata
- Authors
- Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J.-E., Isaacs, J., Kvien, T. K., Mariette, X., Martin-Mola, E., Pavelka, K., Tak, P. P., van der Heijde, D., van Vollenhoven, R. F., & Emery, P.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 70
- Issue
- 6
- Pages
- 909-920
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2411832526
- Cited by
- 453
- References
- 79
- FWCI
- 26.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.